TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer.

Br J Cancer · 2023 · PMC10307892 · PMID 37142730

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In line with our findings, high TXP2 expression co-segregates with the expression of genes associated with gemcitabine resistance, which results in a highly significant correlation of TPX2 expression and a previously described gemcitabine-resistance score [ 18 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.